Hazem Abdelkarim

495 citations
18 papers · 357 indexed · h-index 13
Topics
Histone Deacetylase Inhibitors Research (6 papers)Receptor Mechanisms and Signaling (5 papers)Chemokine receptors and signaling (4 papers)

In The Last Decade

Hazem Abdelkarim

18 papers receiving 350 citations

Peers

Hazem Abdelkarim
Comparison fields: 5 of 66
  • Molecular Biology 229
  • Oncology 97
  • Immunology 79
  • Organic Chemistry 54
  • Physiology 52
Replace Chu Myong Seong with:
Chu Myong Seong South Korea
Xavier Charest‐Morin Canada
Francesca Zonta Italy
Jen‐Chine Wu Taiwan
Giuseppina Claps United States
Kristen Bisanz United States
Niko Schmiedeberg Germany
Tracy Warr United Kingdom
Marie-Anne Goyette Canada
Nathalie Rousselet France
Hazem Abdelkarim relative to Chu Myong Seong South Korea Chu Myong Seong's profile →
Citations per field
00.5×10×14.5×
Chu Myong Seong · 1×
Citations per year

Countries citing papers authored by Hazem Abdelkarim

Since Specialization
Citations

This map shows the geographic impact of Hazem Abdelkarim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hazem Abdelkarim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hazem Abdelkarim more than expected).

Fields of papers citing papers by Hazem Abdelkarim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hazem Abdelkarim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hazem Abdelkarim. The network helps show where Hazem Abdelkarim may publish in the future.

Co-authorship network of co-authors of Hazem Abdelkarim

This figure shows the co-authorship network connecting the top 25 collaborators of Hazem Abdelkarim. A scholar is included among the top collaborators of Hazem Abdelkarim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hazem Abdelkarim. Hazem Abdelkarim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
#WorkIndexed citations
1 14
2 1
3 46
4 5
5 19
6 14
7 14
8 30
9 54
10 7
11 31
12 9
13 33
14 14
15 23
16 11
17 18
18 14

About Hazem Abdelkarim

Hazem Abdelkarim is a scholar working on Oncology, Molecular Biology and Physiology, having authored 18 papers that have together received 357 indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (6 papers), Receptor Mechanisms and Signaling (5 papers) and Chemokine receptors and signaling (4 papers). The work is most often cited by research in Immunology (79 citations), Oncology (97 citations) and Molecular Biology (229 citations). Hazem Abdelkarim has collaborated with scholars based in United States, India and Argentina. Frequent co-authors include Vadim Gaponenko, Pavel A. Petukhov, Aditya S. Vaidya, Gregory R. J. Thatcher, Richard B. van Breemen, Nadya I. Tarasova, Antonett Madriaga, Avik Banerjee, Xianlong Gao and Matthias Majetschak. Their work appears in journals such as PLoS ONE, Oncogene and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026